Abstract:Objective Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), which may lead to inappropriate treatment and poor outcomes. This study aimed to examine prescribing patterns of antidepressants, antipsychotics and mood stabilizers in BD patients misdiagnosed with MDD in China.Methods A total of 1487 patients originally diagnosed with MDD were consecutively screened for diagnostic revision in 13 psychiatric hospitals or psychiatric units of general hospitals in China nationwide. The patients' sociodemographic and clinical characteristics were recorded using a standardized protocol and data collection procedure. The Mini International Neuropsychiatric Interview (MINI) was used to establish DSM-IV diagnoses. Data on psychotropic prescriptions were collected by a review of medical records.Results Three hundred and nine of the 1487 patients (20.8%) fulfilled DSM-IV criteria for BD; 118 (7.9%) for BD-I and 191 (12.8%) for BD-II on the MINI. Of the BD patients (n = 309), 227 (73.5%) received any use of antidepressants, 73 (23.6%) antipsychotics and 33 (10.7%) mood stabilizers. In multiple logistic regression analyses, compared with those with MDD, patients with BD-I were more likely to receive antidepressants (OR 1.7, 95% CI 1.12.8, p = 0.02), antipsychotics (OR 1.6, 95% CI 1.042.5, p = 0.04) and mood stabilizers (OR 3.9, 95% CI 2.17.2, p < 0.001), whereas patients with BD-II were more likely to receive mood stabilizers (OR 2.4, 95% CI 1.34.4, p = 0.003). There was no difference in the use of antidepressants (OR 1.1, 95% CI 0.81.5, p = 0.7) and antipsychotics (OR 1.3, 95% CI 0.91.9, p = 0.2) between BD-II and MDD. In addition, there was no difference between BD-I and BD-II in any use of antidepressants, antipsychotics and mood stabilizers.Conclusions The prescription of antidepressants for BD patients misdiagnosed with MDD is very common, and only a very small proportion of patients received guideline-concordant treatment. Considering the potentially hazardous effects of inappropriate pharmacotherapy in this population, continuing education and training addressing the correct diagnosis of BD and rational use of psychotropic medications are needed in China. Copyright (c) 2012 John Wiley & Sons, Ltd.

Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: a Multicenter Trial Across China.

Screening for Bipolar Disorder with the Mood Disorders Questionnaire in Patients Diagnosed As Major Depressive Disorder — the Experience in China

Hypomanic Symptoms Assessed by the HCL-32 in Patients with Major Depressive Disorder: a Multicenter Trial Across China.

Prescribing Patterns Of Antidepressants, Antipsychotics And Mood Stabilizers In Bipolar Patients Misdiagnosed With Major Depressive Disorder In China

The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders

Application of Chinese Version of Mood Disorder Questionnaire in Patients with Mood Disorder

Gender Differences in Demographic and Clinical Features and Prescribing Patterns of Psychotropic Medications in Patients with Major Depressive Disorder in China

Prescribing Patterns of Psychotropic Medications and Clinical Features in Patients with Major Depressive Disorder with and Without Comorbid Dysthymia in China

Suicide Risk in Major Affective Disorder: Results from a National Survey in China.

Validity of the Chinese Version Mood Disorder Questionnaire (MDQ) and the Optimal Cutoff Screening Bipolar Disorders

Validation of the Nine-Item Patient Health Questionnaire to Screen for Major Depression in A Chinese Primary Care Population

Preliminary utility of Mood Disorder Questionnaire to screen bipolar disorder in depressive patients

Evaluation of a Novel Instrument for Detecting Bipolar Disorders in China: the Rapid Mood Screener (RMS).

Psychometric Properties of the Chinese Version of the Self-Reporting Questionnaire 20 (Srq-20) in Community Settings

The Use of Mood Disorder Questionnaire and Hypomania Checklist-32 for Screening Bipolar Disorder among Outpatients Diagnosed As Major Depressive Disorder in General Hospital

The Application of Chinese Health Questionnaire for Mental Disorder Screening in Community Settings in Mainland China

Screening reported mania symptoms by two self-rating questionnaires from outpatients with depressive disorders in a general hospital

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder.

Implementing machine learning in bipolar diagnosis in China

Psychometric Evaluation of the Major Depression Inventory (MDI) as a Depression Severity Scale in Chinese Patients With Coronary Artery Disease. Findings From the MEDEA FAR-EAST Study.

Validation of the Chinese Version of the Short Temps-A and Its Application in Patients with Mood Disorders